Answers are grounded in this paper and cite their sources.
Despite statin-controlled LDL-C levels, CV events were greater among patients with diabetes and high TG levels. Because we controlled for cardiometabolic risk factors, it is likely that the difference in TG levels contributed to the excess risk observed in patients with high TGs.
No takes yet. Share an insight, caveat, or question.
Nichols et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: